Trade Mark Journal No.2019/052 27 December 2019
WO0000001504629 (5)
Office of origin: United States of America
Date of International Registration:25 October 2019
Date of designation in the UK:
25 October 2019

International priority date claimed: 25 April 2019
(United States of America)
(88401751)
- Class 5
- Pharmaceutical preparations and pharmaceutical agents.
Kadmon Pharmaceuticals, LLC
Representative: Michael J. Leonard Fox Rothschild LLP, 997 Lenox Drive, Bldg. 3, Lawrenceville NJ 08648-2311, UNITED STATES OF AMERICA